Long-Term Real-World Post-approval Safety Data of Multiple Biosimilars from One Marketing-Authorization Holder After More than 18 Years Since Their First Biosimilar Launch. [PDF]
Sagi S +4 more
europepmc +1 more source
समकालीन उपनà¥à¤¯à¤¾à¤¸.
qहदी उपनà¥à¤¯à¤¾à¤¸ विधा का पà¥à¤°à¤šà¤²à¤¨ पाशà¥à¤šà¤¾à¤¤à¥à¤¯ साहितà¥à¤¯ की देन हैŸ। à¤à¤¾à¤°à¤¤à¥‡à¤‚दॠयà¥à¤— में ही इस विधा की बà¥à¤¨à¤¿à¤¯à¤¾à¤¦ रख à ...
सकट, डॉ. हिमालया; मामासाहेब मोहोळ महाविदà¥à¤¯à¤¾à¤²à¤¯ ४८/अ à¤à¤°à¤‚डवणा पौड रोड, पà¥à¤£à¥‡ - ३८.
core
Erratum to: Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System. [PDF]
Rashid N +7 more
europepmc +1 more source
Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients. [PDF]
Miller BS, Yuen KCJ.
europepmc +1 more source
Richard F Pollock,1 Yujun Qian,2 Tami Wisniewski,3 Lisa Seitz,4 Anne-Marie Kappelgaard2 1Ossian Health Economics and Communications GmbH, Basel, Switzerland; 2Novo Nordisk AS, Bagsværd, Denmark; 3Novo Nordisk Inc, Princeton, NJ, USA; 4Novo Nordisk ...
Pollock RF +4 more
core
Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System. [PDF]
Rashid N +7 more
europepmc +1 more source
Acceptability of the reusable SurePal™ self-injection device for Omnitrope(®) among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational study. [PDF]
Partsch CJ +5 more
europepmc +1 more source
वा‘नदादा करà¥à¤¡à¤•ांचà¥à¤™à¥à¤®à¤¾ गीतांचा विचार करत असताना वेगवेगळे पैलू दिसून ङà¥à¤®à¥‡à¤¤à¤¾à¤¤. ते आंबेडकरी चळवळीश
गायकवाड, पà¥à¤°à¤¤à¤¾à¤ª à¤à¤®.; मराठी विà¤à¤¾à¤—पà¥à¤°à¤®à¥à¤–, à¤à¤¸ . à¤à¤¨ .डी.टी. महिला विदà¥à¤¯à¤¾à¤ªà¥€à¤ , पà¥à¤£à¥‡ ३८
core
The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries. [PDF]
Klein K +4 more
europepmc +1 more source
Clinicians' Feedback on Patient/Carer Experience After Switching of Growth Hormone Treatment in Pediatric Patients During COVID-19. [PDF]
Blair J, Warth K, Suvarna Y, Cappa M.
europepmc +1 more source

